颞侧中缝征鉴别青光眼与非青光眼性视神经病变
本研究为横断面研究,纳入175只黄斑区节细胞-内丛状层(mGCIPL)变薄的眼睛,评估mGCIPL厚度图上的颞侧中缝征对鉴别青光眼性视神经病变(GON)与非青光眼性视神经病变(NGON)的价值。结果显示,颞侧中缝征在GON眼中出现率(91.0%)显著高于NGON眼(28.8%),其诊断GON的AUC为0.811,基于决策树的模型AUC达0.879,优于单独使用颞侧中缝征或相对性传入性瞳孔缺陷(RAPD)。
要点
- 颞侧中缝征在GON眼中阳性率91.0%,NGON眼中仅28.8%(P<0.001)。
- 颞侧中缝征诊断GON的AUC为0.811,敏感度91.0%,特异度71.2%。
- 决策树模型(结合RAPD)AUC 0.879,优于单独指标(P=0.005和P<0.001)。
核心结论
- 在mGCIPL变薄眼中,OCT黄斑扫描上的颞侧中缝征有助于鉴别青光眼性与非青光眼性视神经病变。
- 结合颞侧中缝征与RAPD的决策树模型诊断性能优于单独使用任一指标。
研究设计与样本
- 横断面研究,回顾性纳入175例(175眼)Cirrus高清晰度OCT显示mGCIPL变薄的患者。
- 由青光眼专家和神经眼科专家根据病历资料共同诊断,最终纳入67只GON眼和73只NGON眼进行分析。
主要发现
- 颞侧中缝征在GON眼出现61/67只(91.0%),在NGON眼出现21/73只(28.8%),差异有统计学意义(P<0.001,卡方检验)。
- 颞侧中缝征诊断GON的AUC为0.811(95%CI 0.749-0.874),敏感度91.0%,特异度71.2%。
- 决策树模型诊断GON的AUC为0.879(95%CI 0.824-0.933),敏感度88.1%,特异度87.7%。
- 决策树模型性能优于单独颞侧中缝征(P=0.005)和单独RAPD(P<0.001)(DeLong检验)。
关键数值与推荐
- 颞侧中缝征阳性定义为mGCIPL厚度图颞侧椭圆区内出现长度超过内环与外环间距一半的直线。
- 决策树规则:若颞侧中缝征阳性且RAPD阴性,诊断为GON;若颞侧中缝征阴性(无论RAPD是否存在),或颞侧中缝征与RAPD均阳性,诊断为NGON。
临床怎么用
- 对于OCT发现mGCIPL变薄的患者,可观察颞侧中缝征辅助鉴别青光眼与非青光眼性视神经病变。
- 结合RAPD状态应用决策树模型可提高鉴别诊断的准确性。
局限性
- 本研究为回顾性横断面设计,样本来自单中心,可能存在选择偏倚。
- 原文未报告亚组分析、重复测量或外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the potential of the temporal raphe sign on the macular ganglion cell-inner plexiform layer (mGCIPL) thickness map for discriminating glaucomatous from nonglaucomatous optic neuropathy (NGON) in eyes with mGCIPL thinning. DESIGN: Cross-sectional study. PARTICIPANTS: A total of 175 eyes of 175 patients with mGCIPL thinning on Cirrus (Carl Zeiss Meditec, Dublin, CA) high-definition OCT were retrospectively included. Glaucoma specialists and neuro-ophthalmology specialists evaluated the patients' medical records for diagnosis of glaucomatous optic neuropathy (GON) or NGON. Finally, by consensus, 67 eyes with GON and 73 eyes with NGON were enrolled. METHODS: A positive temporal raphe sign was declared in patients in whom there was a straight line longer than one-half of the length between the inner and outer annulus in the temporal elliptical area of the mGCIPL thickness map. Decision tree analysis was performed to formulate a diagnostic model. MAIN OUTCOME MEASURES: Area under receiver operating characteristic curve (AUC) with sensitivity and specificity. RESULTS: The temporal raphe sign was observed in 61 of 67 GON eyes (91.0%), but in only 21 of 73 NGON eyes (28.8%) (P < 0.001; chi-square test). On this basis, the diagnostic ability of the temporal raphe sign for discriminating GON from NGON was judged to be good (AUC, 0.811; 95% confidence interval, 0.749-0.874; sensitivity, 91.0%; specificity, 71.2%). The diagnostic performance of the decision tree-based model (AUC 0.879; 95% confidence interval, 0.824-0.933; sensitivity, 88.1%; specificity, 87.7%) was better than that of the temporal raphe sign or the relative afferent pupillary defect (RAPD) alone (P = 0.005, P < 0.001, respectively; DeLong's test). The decision tree model revealed the following: (1) If the temporal raphe sign is positive and the RAPD is absent, the case should be diagnosed as GON; (2) if the temporal raphe sign is absent regardless of the presence or absence of the RAPD, or both the temporal raphe sign and the RAPD are present, the case should be diagnosed as NGON. CONCLUSIONS: In clinical practice, determining whether the temporal raphe sign appears on OCT macular scans can be a useful tool for discrimination of glaucomatous from nonglaucomatous mGCIPL thinning.
引用
- Lee J, Kim YK, Ha A, et al. Temporal Raphe Sign for Discrimination of Glaucoma from Optic Neuropathy in Eyes with Macular Ganglion Cell-Inner Plexiform Layer Thinning. Ophthalmology. 2018. PMID: 30576683. doi:10.1016/j.ophtha.2018.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。